3
Disclosures
Jan 20, 2026 — Mar 24, 2026
Date Range
PRIME
Market Segment

Disclosures

DateTypeHeadlinePDF
Mar 24 Other Shionogi &: Shionogi to Acquire Full Stake in Shionogi-Apnimed Sleep Science PDF
Mar 23 Loan Shionogi &: Secures Bridge Loan for Edaravone Business Acquisition PDF
Mar 23 Other Shionogi &: Shionogi Secures Approval for Zocova as Post-Exposure Prevention for COVID-19 PDF

Disclosure Types

Other: 2 Loan: 1